3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
2
Sarcoma, Synovial
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
PRETEXT I Hepatoblastoma
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Localized Extraskeletal Ewing Sarcoma
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Ganglioneuroblastoma
1
Fibrosarcoma
1
Dermatofibrosarcoma
1
Central Nervous System Neoplasms
1
Interventions
Rituximab
9
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
fludarabine phosphate
6
Cyclophosphamide
6
Etoposide
5
Tacrolimus
4
Mycophenolic Acid
4
Cyclosporine
4
Carboplatin
4
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Busulfan
3
Thiotepa
2
Melphalan
2
Lenalidomide
2
Ipilimumab
2
Dexamethasone
2
Calcium Dobesilate
2
CTLA-4 Antigen
2
Bendamustine Hydrochloride
2
Antilymphocyte Serum
2
veliparib
1
sodium thiosulfate
1
pegfilgrastim
1
oblimersen
1
merphos
1
etoposide phosphate
1
Vorinostat
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Intraocular Lymphoma
×
Razoxane
×
Clear all
No trials found.